Tarsus Pharmaceuticals, Inc. (TARS)
80.28
+3.39
(+4.41%)
USD |
NASDAQ |
Nov 13, 16:00
80.40
+0.12
(+0.15%)
After-Hours: 19:59
Tarsus Pharmaceuticals Market Cap : 3.958B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.958B |
| November 12, 2026 | 3.791B |
| November 11, 2026 | 3.785B |
| November 10, 2026 | 3.640B |
| November 09, 2026 | 3.493B |
| November 06, 2026 | 3.382B |
| November 05, 2026 | 3.329B |
| November 04, 2026 | 3.405B |
| November 03, 2026 | 3.581B |
| November 02, 2026 | 3.615B |
| October 30, 2026 | 3.690B |
| October 29, 2026 | 3.211B |
| October 28, 2026 | 3.118B |
| October 27, 2026 | 3.062B |
| October 26, 2026 | 3.030B |
| October 23, 2026 | 2.951B |
| October 22, 2026 | 3.119B |
| October 21, 2026 | 3.051B |
| October 20, 2026 | 3.074B |
| October 19, 2026 | 3.007B |
| October 16, 2026 | 2.945B |
| October 15, 2026 | 3.072B |
| October 14, 2026 | 3.128B |
| October 13, 2026 | 3.064B |
| October 12, 2026 | 3.219B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.166B |
| October 08, 2026 | 3.125B |
| October 07, 2026 | 3.185B |
| October 06, 2026 | 3.207B |
| October 05, 2026 | 3.222B |
| October 02, 2026 | 3.159B |
| October 01, 2026 | 3.265B |
| September 30, 2026 | 3.402B |
| September 29, 2026 | 3.318B |
| September 28, 2026 | 3.324B |
| September 25, 2026 | 3.275B |
| September 24, 2026 | 3.287B |
| September 23, 2026 | 3.215B |
| September 22, 2026 | 3.335B |
| September 21, 2026 | 3.352B |
| September 18, 2026 | 3.379B |
| September 17, 2026 | 3.420B |
| September 16, 2026 | 3.360B |
| September 15, 2026 | 3.385B |
| September 14, 2026 | 3.460B |
| September 11, 2026 | 3.432B |
| September 10, 2026 | 3.510B |
| September 09, 2026 | 3.582B |
| September 08, 2026 | 3.774B |
| September 04, 2026 | 3.928B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 129.65B |
| Amneal Pharmaceuticals, Inc. | 7.448B |
| Harmony Biosciences Holdings, Inc. | 1.982B |
| ANI Pharmaceuticals, Inc. | 1.636B |
| Corcept Therapeutics, Inc. | 7.977B |
Market Cap Related Metrics
| PS Ratio | 5.165 |
| PEG Ratio | -0.0081 |
| Price to Book Value | 38.05 |
| Price to Free Cash Flow | 108.61 |
| Price | 80.28 |
| Earnings Yield | -18.91% |
| PEGY Ratio | -0.0081 |